Table 2.
Examples of Mechanisms Implicated in Diabetic Microvascular Disease
Risk factors: Hyperglycemia | ||||
---|---|---|---|---|
Targets: Endothelium, Podocytes, Pericytes, VSMCs | ||||
Increased aldose reductase pathway |
Protein kinase activation |
Increased oxidative stress |
Protein glycation |
Increased hexosamine pathway |
↑Sorbitol: Osmotic cellular damage ↓(Na+ & K+) ATPase activity ↑NADH/NAD+ ↓NADPH |
↑VEGF ↑ROS NF-κB activation Inhibition of eNOS activity ↑Endothelin-1 |
↑ROS | ↑AGE Apoptotic death NFκB activation ↑ROS |
↑PAI-1 Inhibition of eNOS activity |
VSMCs = vascular smooth muscle cells; eNOS = endothelial nitric oxide synthase; NAD = nicotine adenine dinucleotide; NADH = nicotine adenine dinucleotide reduced; NADPH = nicotine adenine dinucleotide phosphate reduced; PAI-1 = plasminogen activator inhibitor-1; ROS = reactive oxygen species; VEGF = vascular endothelial growth factor; other abbreviations as in Table 1.